Thank you for attending the SOT Annual Meeting March 11–15, 2012!
Mark your calendar SOT Annual Meeting March 10–14, 2013.
Submit Session Proposals Now—April 30.
AstraZeneca Pharmaceuticals LP
Bristol–Myers Squibb Company
Charles River
Abbott Laboratories Ani Lytics, Inc. Burroughs Wellcome Fund Covance Inc. GlaxoSmithKline National Center for Toxicological Research (NCTR) RTC, Research Toxicology Centre S.p.A. Sanofi ToxServices LLC WIL Research
Abbott Laboratories
Ani Lytics, Inc.
Burroughs Wellcome Fund
Covance Inc.
GlaxoSmithKline
National Center for Toxicological Research (NCTR)
RTC, Research Toxicology Centre S.p.A.
Sanofi
ToxServices LLC
WIL Research
AllCells, LLC The Allergan Foundation ArunA Biomedical, Inc. BASi (Bioanalytical Systems, Inc.) BioReliance Corporation Chemical Research in Toxicology Chevron Corporation Eastman Charitable Foundation Gradient PointCross Life Sciences SRI International WuXi AppTec
AllCells, LLC
The Allergan Foundation
ArunA Biomedical, Inc.
BASi (Bioanalytical Systems, Inc.)
BioReliance Corporation
Chemical Research in Toxicology
Chevron Corporation
Eastman Charitable Foundation
Gradient
PointCross Life Sciences
SRI International
WuXi AppTec
Calvert Laboratories, Inc. EPL, Inc. (Experimental Pathology Laboratories) ExxonMobil HemoShear, LLC Research Institute for Fragrance Materials, Inc. Toxicology Excellence for Risk Assessment (TERA)
Calvert Laboratories, Inc.
EPL, Inc. (Experimental Pathology Laboratories)
ExxonMobil
HemoShear, LLC
Research Institute for Fragrance Materials, Inc.
Toxicology Excellence for Risk Assessment (TERA)
Daiichi Sankyo Company Limited Eisai, Inc. SafeBridge Consultants, Inc.
Daiichi Sankyo Company Limited
Eisai, Inc.
SafeBridge Consultants, Inc.
SOT —Dedicated to Creating a Safer and Healthier World by Advancing the Science of Toxicology.
© 2012 Society of Toxicology. All rights reserved.
Privacy Policy and Disclaimer | Contact Us